These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35433091)

  • 1. COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.
    Smith DJ; Hakim AJ; Leung GM; Xu W; Schluter WW; Novak RT; Marston B; Hersh BS
    China CDC Wkly; 2022 Apr; 4(14):288-292. PubMed ID: 35433091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.
    Smith DJ; Hakim AJ; Leung GM; Xu W; Schluter WW; Novak RT; Marston B; Hersh BS
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(15):545-548. PubMed ID: 35421076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between COVID-19 Vaccination Coverage and Case Fatality Ratio: a Comparative Study - Hong Kong SAR, China and Singapore, December 2021-March 2022.
    He G; Zhu S; Fu D; Xiao J; Zhao J; Lin Z; Liu T; Liang X; Ma W
    China CDC Wkly; 2022 Jul; 4(30):649-654. PubMed ID: 36062069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.
    McMenamin ME; Nealon J; Lin Y; Wong JY; Cheung JK; Lau EHY; Wu P; Leung GM; Cowling BJ
    Lancet Infect Dis; 2022 Oct; 22(10):1435-1443. PubMed ID: 35850128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
    Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
    Lancet; 2022 Oct; 400(10359):1213-1222. PubMed ID: 36216007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Value of Vaccines to Address the COVID-19 Pandemic in Hong Kong: A Cost-Effectiveness Analysis.
    Xiong X; Li J; Huang B; Tam T; Hong Y; Chong KC; Huo Z
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.
    Wan EYF; Wang Y; Chui CSL; Mok AHY; Xu W; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Lau KK; Cowling BJ; Hung IFN; Wong ICK
    Lancet Healthy Longev; 2022 Jul; 3(7):e491-e500. PubMed ID: 35813276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases.
    Zhao S; Guo Z; Sun S; Hung CT; Leung EYM; Wei Y; Wang H; Li K; Yam CHK; Chow TY; Gao J; Jia KM; Chong KC; Yeoh EK
    J Clin Virol; 2023 Sep; 166():105547. PubMed ID: 37453162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health impact of herpes zoster vaccination on older adults in Hong Kong.
    Chan PKS; Wong MCS; Chan M; Ching K; Giannelos N; Ng C
    Hum Vaccin Immunother; 2023 Dec; 19(1):2176065. PubMed ID: 36854447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.
    Singh A; Lai AHY; Wang J; Asim S; Chan PS; Wang Z; Yeoh EK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e31707. PubMed ID: 34653014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
    Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
    Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.
    Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ
    Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination Preferences Among Non-Chinese Migrants in Hong Kong: Discrete Choice Experiment.
    Asim S; Wang K; Nichini E; Yip FF; Zhu L; Fung HCE; Zeng Y; Fang Z; Cheung AW; Wong EL; Dong D; Yeoh EK
    JMIR Public Health Surveill; 2023 Mar; 9():e40587. PubMed ID: 36848242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: the impact of influenza and pneumococcal vaccination.
    Yang L; Chan KP; Wong CM; Chiu SSS; Magalhaes RJS; Thach TQ; Peiris JSM; Clements ACA; Hu W
    BMC Infect Dis; 2019 Feb; 19(1):162. PubMed ID: 30764779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong.
    Zhou R; Liu N; Li X; Peng Q; Yiu CK; Huang H; Yang D; Du Z; Kwok HY; Au KK; Cai JP; Fan-Ngai Hung I; Kai-Wang To K; Xu X; Yuen KY; Chen Z
    Lancet Reg Health West Pac; 2023 Mar; 32():100660. PubMed ID: 36591327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
    Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jul; ():. PubMed ID: 35898339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.